Avani Kanubaddi's most recent trade in Enveric Biosciences Inc was a trade of 10,000 Common Stock done . Disclosure was reported to the exchange on Jan. 25, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Enveric Biosciences Inc | Avani Kanubaddi | President and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 10,000 | 48,346 (1%) | 0% | 0 | Common Stock | |
| Enveric Biosciences Inc | Avani Kanubaddi | President and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2022 | 1,127,787 | 1,127,787 | - | - | Restricted Stock Units | |
| Enveric Biosciences Inc | Avani Kanubaddi | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2021 | 789,484 | 789,484 | - | - | Restricted Stock Units |